Skip to Content

C25 (Rubraca 250 mg)

Generic Name: rucaparib

Pill with imprint C25 is White, Four-sided and has been identified as Rubraca 250 mg. It is supplied by Clovis Oncology, Inc..

Rubraca is used in the treatment of ovarian cancer and belongs to the drug class PARP inhibitors. Rubraca 250 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for C25

Rubraca

Generic Name:
rucaparib
Imprint:
C25
Strength:
250 mg
Color:
White
Shape:
Four-sided
Availability:
Prescription only
Drug Class:
PARP inhibitors
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Clovis Oncology, Inc.
Manufacturer:
Clovis Oncology, Inc.
National Drug Code (NDC):
69660-0202

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide